Antisecretory factor effectively and safely stops childhood diarrhoea: a placebo-controlled, randomised study

Area of Science:

• Pediatrics
• Gastroenterology
• Nutritional Science

Background:

• Acute diarrhea is a leading cause of childhood illness globally.
• Antisecretory factor (AF) found in egg yolk shows potential therapeutic benefits.
• Limited research exists on high-dose AF efficacy in pediatric acute diarrhea.

Purpose of the Study:

• To evaluate the effectiveness and safety of high-dose Salovum® (egg yolk with AF) in treating acute diarrhea in young children.
• To compare the treatment outcomes of Salovum® versus placebo in a pediatric population.

Main Methods:

• A randomized, placebo-controlled trial was conducted with 36 children (7-60 months) presenting with acute diarrhea.
• Participants received either 16g Salovum® or placebo initially, followed by 8g every 5 hours until recovery.
• Stool frequency and consistency were primary outcome measures.

Main Results:

• Salovum® significantly reduced stool frequency (7 vs. 18 hours) and normalized stool consistency (10 vs. 18 hours) compared to placebo.
• The overall treatment duration was notably shorter in the Salovum® group (35 vs. 70 hours).
• No adverse side effects were reported during the trial.

Conclusions:

• High-dose Salovum® is an effective and safe intervention for reducing childhood acute diarrhea.
• AF-rich egg yolk offers a promising therapeutic option for diarrhea of diverse etiologies in children.
• Further research into AF's broad applicability in pediatric gastrointestinal disorders is warranted.